Literature DB >> 16500018

Comparison of 30 and the 100% inspired oxygen concentrations during early post-resuscitation period: a randomised controlled pilot study.

M Kuisma1, J Boyd, V Voipio, A Alaspää, R O Roine, P Rosenberg.   

Abstract

OBJECTIVES: High oxygen concentration in blood may be harmful in the reperfusion phase after cardiopulmonary resuscitation. We compared the effect of 30 and 100% inspired oxygen concentrations on blood oxygenation and the level of serum markers (NSE, S-100) of neuronal injury during the early post-resuscitation period in humans.
METHODS: Patients resuscitated from witnessed out-of-hospital ventricular fibrillation were randomised after the return of spontaneous circulation (ROSC) to be ventilated either with 30% (group A) or 100% (group B) oxygen for 60 min. Main outcome measures were NSE and S-100 levels at 24 and 48 h after ROSC, the adequacy of oxygenation at 10 and 60 min after ROSC and, in group A, the need to raise FiO(2) to avoid hypoxaemia. Blood oxygen saturation <95% was the threshold for this intervention.
RESULTS: Thirty-two patients were randomised and 28 (14 in group A and 14 in group B) remained eligible for the final analysis. The mean PaO(2) at 10 min was 21.1 kPa in group A and 49.7 kPa in group B. The corresponding values at 60 min were 14.6 and 46.5 kPa. PaO(2) values did not fall to the hypoxaemic level in group A. In another group FiO(2) had to be raised in five cases (36%) but in two cases it was returned to 0.30 rapidly. The mean NSE at 24 and 48 h was 10.9 and 14.2 microg/l in group A and 13.0 and 18.6 microg/l in group B (ns). S-100 at corresponding time points was 0.21 and 0.23 microg/l in group A and 0.73 and 0.49 microg/l in group B (ns). In the subgroup not treated with therapeutic hypothermia in hospital NSE at 24h was higher in group B (mean 7.6 versus 13.5 microg/l, p=0.0487).
CONCLUSIONS: Most patients had acceptable arterial oxygenation when ventilated with 30% oxygen during the immediate post-resuscitation period. There was no indication that 30% oxygen with SpO(2) monitoring and oxygen backup to avoid SpO(2)<95% did worse that the group receiving 100% oxygen. The use of 100% oxygen was associated with increased level of NSE at 24h in patients not treated with therapeutic hypothermia. The clinical significance of this finding is unknown and an outcome-powered study is feasible.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16500018     DOI: 10.1016/j.resuscitation.2005.08.010

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  39 in total

1.  Human brain blood flow and metabolism during isocapnic hyperoxia: the role of reactive oxygen species.

Authors:  João D Mattos; Monique O Campos; Marcos P Rocha; Daniel E Mansur; Helena N M Rocha; Vinicius P Garcia; Gabriel Batista; Thiago S Alvares; Gustavo V Oliveira; Mônica V Souza; Rogério L R Videira; Natalia G Rocha; Niels H Secher; Antonio C L Nóbrega; Igor A Fernandes
Journal:  J Physiol       Date:  2018-12-26       Impact factor: 5.182

2.  Hyperoxia following cardiac arrest.

Authors:  Jonathan Ball; Otavio T Ranzani
Journal:  Intensive Care Med       Date:  2015-01-29       Impact factor: 17.440

Review 3.  Intensive care medicine research agenda on cardiac arrest.

Authors:  Jerry P Nolan; Robert A Berg; Stephen Bernard; Bentley J Bobrow; Clifton W Callaway; Tobias Cronberg; Rudolph W Koster; Peter J Kudenchuk; Graham Nichol; Gavin D Perkins; Tom D Rea; Claudio Sandroni; Jasmeet Soar; Kjetil Sunde; Alain Cariou
Journal:  Intensive Care Med       Date:  2017-03-11       Impact factor: 17.440

4.  Oxygen and carbon dioxide targets during and after resuscitation of cardiac arrest patients.

Authors:  M B Skrifvars; T M Olasveengen; Giuseppe Ristagno
Journal:  Intensive Care Med       Date:  2018-11-12       Impact factor: 17.440

Review 5.  Part 8: Post-Cardiac Arrest Care: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

Authors:  Clifton W Callaway; Michael W Donnino; Ericka L Fink; Romergryko G Geocadin; Eyal Golan; Karl B Kern; Marion Leary; William J Meurer; Mary Ann Peberdy; Trevonne M Thompson; Janice L Zimmerman
Journal:  Circulation       Date:  2015-11-03       Impact factor: 29.690

Review 6.  Oxygen Treatment in Intensive Care and Emergency Medicine.

Authors:  Jörn Grensemann; Valentin Fuhrmann; Stefan Kluge
Journal:  Dtsch Arztebl Int       Date:  2018-07-09       Impact factor: 5.594

7.  Association Between Early Hyperoxia Exposure After Resuscitation From Cardiac Arrest and Neurological Disability: Prospective Multicenter Protocol-Directed Cohort Study.

Authors:  Brian W Roberts; J Hope Kilgannon; Benton R Hunter; Michael A Puskarich; Lisa Pierce; Michael Donnino; Marion Leary; Jeffrey A Kline; Alan E Jones; Nathan I Shapiro; Benjamin S Abella; Stephen Trzeciak
Journal:  Circulation       Date:  2018-02-01       Impact factor: 29.690

8.  Post-resuscitation arterial oxygen and carbon dioxide and outcomes after out-of-hospital cardiac arrest.

Authors:  Henry E Wang; David K Prince; Ian R Drennan; Brian Grunau; David J Carlbom; Nicholas Johnson; Matthew Hansen; Jonathan Elmer; Jim Christenson; Peter Kudenchuk; Tom Aufderheide; Myron Weisfeldt; Ahamed Idris; Stephen Trzeciak; Michael Kurz; Jon C Rittenberger; Denise Griffiths; Jamie Jasti; Susanne May
Journal:  Resuscitation       Date:  2017-09-21       Impact factor: 5.262

Review 9.  Outcome measures utilized in clinical trials of interventions for post-cardiac arrest syndrome: a systematic review.

Authors:  Stephen Trzeciak; Alan E Jones; J Hope Kilgannon; Brian M Fuller; Brian W Roberts; Joseph E Parrillo; John T Farrar
Journal:  Resuscitation       Date:  2009-04-21       Impact factor: 5.262

10.  Cardio-renal recovery of hypoxic newborn pigs after 18%, 21% and 100% reoxygenation.

Authors:  Po-Yin Cheung; Laila Obaid; Marwan Emara; Yann Brierley; Scott T Johnson; Grace S Chan; Laurence Jewell; Gregory Korbutt; David L Bigam
Journal:  Intensive Care Med       Date:  2008-01-31       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.